Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial

Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    0.5%
    Check dated 2026-10-26T14:36:10.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:51:06.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T15:56:01.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.7.0 was added to the study history, and the prior revision v3.6.6 was removed, updating the version history displayed on the page.
    Difference
    0.1%
    Check dated 2026-09-21T20:38:20.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The history shows a new revision entry updating the page to version v3.6.6, signaling a small system update to the record history interface.
    Difference
    0.1%
    Check dated 2026-08-31T16:34:08.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, signaling a newer site build; no study record content or history entries were modified.
    Difference
    0.1%
    Check dated 2026-08-10T06:51:55.000Z thumbnail image

Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.